Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.92M Buy
19,120
+7,070
+59% +$2.42M 0.22% 132
2026
Q1
$4.24M Sell
12,050
-1,050
-8% -$374K 0.15% 165
2025
Q4
$4.29M Sell
13,100
-650
-5% -$206K 0.15% 161
2025
Q3
$3.88M Sell
13,750
-100
-0.7% -$29K 0.13% 165
2025
Q2
$3.87M Buy
13,850
+150
+1% +$42.5K 0.13% 166
2025
Q1
$4.27M Buy
13,700
+350
+3% +$103K 0.14% 164
2024
Q4
$3.48M Buy
13,350
+250
+2% +$74.2K 0.1% 184
2024
Q3
$4.22M Sell
13,100
-200
-2% -$65.4K 0.14% 164
2024
Q2
$4.16M Buy
13,300
+100
+0.8% +$29.4K 0.16% 161
2024
Q1
$3.75M Sell
13,200
-2,300
-15% -$673K 0.16% 157
2023
Q4
$4.46M Buy
15,500
+6,200
+67% +$1.69M 0.23% 124
2023
Q3
$2.5M Sell
9,300
-200
-2% -$49.9K 0.18% 150
2023
Q2
$2.11M Sell
9,500
-550
-5% -$128K 0.15% 175
2023
Q1
$2.43M Sell
10,050
-24,700
-71% -$6.06M 0.18% 169
2022
Q4
$9.13M Sell
34,750
-10,000
-22% -$2.68M 0.6% 50
2022
Q3
$10.1M Buy
44,750
+100
+0.2% +$24.2K 0.7% 39
2022
Q2
$10.9M Sell
44,650
-200
-0.4% -$49K 0.65% 38
2022
Q1
$10.8M Buy
44,850
+13,800
+44% +$3.17M 0.57% 46
2021
Q4
$6.99M Buy
31,050
+8,900
+40% +$1.88M 0.4% 86
2021
Q3
$4.71M Buy
22,150
+1,950
+10% +$449K 0.28% 128
2021
Q2
$4.92M Buy
20,200
+1,150
+6% +$283K 0.27% 132
2021
Q1
$4.74M Sell
19,050
-12,150
-39% -$2.9M 0.28% 131
2020
Q4
$7.17M Sell
31,200
-1,600
-5% -$369K 0.46% 68
2020
Q3
$8.34M Sell
32,800
-700
-2% -$173K 0.58% 53
2020
Q2
$7.9M Sell
33,500
-900
-3% -$205K 0.55% 53
2020
Q1
$6.97M Sell
34,400
-3,400
-9% -$743K 0.52% 55
2019
Q4
$9.11M Sell
37,800
-2,200
-6% -$485K 0.46% 70
2019
Q3
$7.74M Sell
40,000
-1,100
-3% -$211K 0.39% 71
2019
Q2
$7.57M Sell
41,100
-100
-0.2% -$17.9K 0.36% 77
2019
Q1
$7.83M Buy
41,200
+11,000
+36% +$2.1M 0.36% 77
2018
Q4
$5.88M Sell
30,200
-1,100
-4% -$215K 0.29% 91
2018
Q3
$6.49M Hold
31,300
0.24% 97
2018
Q2
$5.78M Hold
31,300
0.2% 116
2018
Q1
$5.34M Buy
+31,300
New +$5.75M 0.18% 125

Other funds holding AMGN

Hennessy Advisors Inc's AMGN Position: Q2 2026 in Review

Hennessy Advisors Inc increased its Amgen (AMGN) stake by 59% in Q2 2026, buying an estimated $2.42M and bringing the position to 19,120 shares worth $6.92M. The position accounts for 0.22% of the portfolio, ranked #132.

Hennessy Advisors Inc first reported a position in AMGN in Q1 2018 and has held it in 34 quarters since. The position peaked at $10.9M in Q2 2022. 1,152 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hennessy Advisors Inc held 19,120 shares of Amgen worth $6.92M as of Q2 2026.
  • Hennessy Advisors Inc bought 7,070 Amgen shares in Q2 2026, an estimated $2.42M.
  • Amgen made up 0.22% of Hennessy Advisors Inc's portfolio in Q2 2026, its #132 holding.
  • Hennessy Advisors Inc first reported a position in Amgen in Q1 2018 and has held it in 34 quarters since.
  • Hennessy Advisors Inc's Amgen position peaked at $10.9M in Q2 2022.
  • 1,152 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hennessy Advisors Inc's 13F filing for Q2 2026, filed 16 Jul 2026.